Abstract
Objective. Proton pencil-beam scanning arcs (PBS arcs) have gained much attention during the past years, due to its potential for increased clinical benefit compared to conventional proton therapy. Previous studies on PBS arcs have primarily been focused on plan quality, and lately efforts have been made to reduce the delivery time. However, the methods presented so far suffer from slow optimization processes. Approach. We present a new method for fast robust optimization of PBS arc plans. The new method assigns a single energy layer per discretized direction prior to spot weight optimization and reduces the number of initial spots considerably compared to conventional methods. We used the new method for three prostate cancer patients with a prescribed dose to the CTV of 77 GyRBE in 35 fractions. For each of the patients, four plans were created: 2-beam IMPT (2IMPT), 1-beam PBS arc (1Arc), 1-beam PBS arc without focus on reducing upward energy jumps (1Arc_unseq) and two-beam PBS arc (2Arc). Main results. All PBS arc plans show a reduced integral dose compared to their respective 2IMPT plans. In the nominal case, the average CTV D98 and D2 metrics over the three patients were best for the 2Arc, followed by 2IMPT (/ 7523/7986 cGyRBE (2IMPT), 7478/7984 cGy (1Arc), 7486/7951 cGy (1Arc_unseq), 7531/7951 cGyRBE (2Arc)). The average robust target coverage in terms of V95 of the voxelwise minimum dose distribution (evaluated over 42 scenarios) was: 98.0% (2IMPT), 88.6% (1Arc), 92.5% (1Arc_unseq), 97.3% (2Arc). The optimization time, including spot selection and spot dose computation, is longest for the 2Arc plan, but is below 6 min for all patients. The maximum estimated delivery time for all types of arc plans is just above 5 min Significance. The ability for efficient treatment planning constitutes an important step towards clinical introduction of proton PBS arcs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.